Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and D

Eur Respir J. 2015 Jul;46(1):255-8. doi: 10.1183/09031936.00047115. Epub 2015 May 28.

¹ Department of Pulmonary/Critical Care, University of Texas Health Sciences Centre, and South Texas Veterans Healthcare System, San Antonio, TX, USA [email protected].
² The George Institute for Global Health, Sydney, Australia.
³ Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, University of Colorado, Denver, CO, USA.
⁴ AstraZeneca R&D, Mölndal, Sweden.
⁵ Pulmonary and Rehabilitation Research Group, University Hospital Aintree, Liverpool, UK.
⁶ University of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands.
⁷ Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska Medical Center, Omaha, NE, USA.
⁸ David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

No abstract available

Publication types